Autobio Diagnostics Co., Ltd. (SHA: 603658)

Autobio Diagnostics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	320.87	1,486	1,138	769.4	327.55	136.88
Short-Term Investments	-	2,333	3,141	3,000	3,092	611.04
Trading Asset Securities	511.28	700.57	-	7.34	85.89	120.16
Cash & Short-Term Investments	832.15	4,521	4,278	3,777	3,505	868.09
Cash Growth	87.82%	5.66%	13.27%	7.75%	303.80%	123.25%
Accounts Receivable	1,246	1,181	1,074	1,003	958.87	636.46
Other Receivables	41.54	24.25	34.86	31.69	45.27	37.39
Receivables	1,288	1,206	1,109	1,035	1,004	673.85
Inventory	931.11	778.29	752.3	589.34	475.52	342.22
Prepaid Expenses	-	-	-	-	-	3.2
Other Current Assets	3,084	108.54	113.63	156.62	109.75	129.93
Total Current Assets	6,135	6,613	6,254	5,558	5,095	2,017
Property, Plant & Equipment	4,071	3,883	3,293	2,864	2,276	1,536
Long-Term Investments	144.32	123.31	13.76	1.72	83.42	104.27
Goodwill	164.65	164.65	164.65	164.65	164.65	171.03
Other Intangible Assets	156.74	179.03	203.27	227.85	252.2	272.37
Long-Term Deferred Tax Assets	314.7	274.61	238.73	201.76	157.83	104.26
Long-Term Deferred Charges	77.3	179.23	169.97	137.11	104.66	43.9
Other Long-Term Assets	326.15	137.55	135.59	78.07	3.21	8.06
Total Assets	11,389	11,554	10,472	9,233	8,137	4,257
Accounts Payable	971.86	726.15	1,010	355.24	438.73	180.8
Accrued Expenses	108.65	364.54	335.93	238.07	161.57	113.58
Short-Term Debt	253.7	353.28	113.84	121.39	206.63	349.12
Current Portion of Long-Term Debt	302.66	342	-	100.08	-	-
Current Portion of Leases	-	10.93	12.56	9.78	-	-
Current Income Taxes Payable	106.11	137.85	86.48	77.62	28.95	18.47
Current Unearned Revenue	54.52	148.14	135.48	125.1	95.86	37.14
Other Current Liabilities	590.44	400.25	472.27	431.28	325.19	287.93
Total Current Liabilities	2,388	2,483	2,167	1,459	1,257	987.04
Long-Term Debt	-	-	-	-	-	503.06
Long-Term Leases	23.41	24.64	16.26	26.16	-	-
Long-Term Unearned Revenue	199.85	118.98	101.77	75.68	58.29	3.99
Long-Term Deferred Tax Liabilities	287.23	258.03	273.03	269.1	236.61	128.21
Other Long-Term Liabilities	4.93	2.92	2.22	-	-	-
Total Liabilities	2,903	2,888	2,560	1,829	1,552	1,622
Common Stock	581.01	586.27	586.27	586.27	450.98	420
Additional Paid-In Capital	3,819	4,101	4,101	4,101	4,250	536.14
Retained Earnings	4,438	4,091	3,338	2,590	1,771	1,411
Treasury Stock	-436.67	-243.3	-243.3	-	-	-
Comprehensive Income & Other	0.89	1.03	0.61	-0.07	5.25	190.16
Total Common Equity	8,402	8,535	7,783	7,277	6,477	2,557
Minority Interest	83.74	130.87	129.59	126.49	107.95	77.65
Shareholders' Equity	8,486	8,666	7,912	7,403	6,585	2,635
Total Liabilities & Equity	11,389	11,554	10,472	9,233	8,137	4,257
Total Debt	579.77	730.85	142.66	257.4	206.63	852.17
Net Cash (Debt)	252.38	3,790	4,136	3,520	3,299	15.92
Net Cash Growth	-	-8.36%	17.50%	6.70%	20626.03%	-94.46%
Net Cash Per Share	0.44	6.54	7.09	6.00	5.91	0.03
Filing Date Shares Outstanding	572.12	581.01	581.01	586.27	586.27	559.78
Total Common Shares Outstanding	572.12	581.01	581.01	586.27	586.27	546
Working Capital	3,747	4,130	4,087	4,099	3,838	1,030
Book Value Per Share	14.69	14.69	13.39	12.41	11.05	4.68
Tangible Book Value	8,081	8,192	7,415	6,884	6,061	2,114
Tangible Book Value Per Share	14.12	14.10	12.76	11.74	10.34	3.87
Buildings	-	1,152	829.25	473.02	472.47	428.49
Machinery	-	2,740	2,492	2,283	1,892	1,273
Construction In Progress	-	1,591	1,272	1,105	641.8	329.56

Source: S&P Capital IQ. Standard template. Financial Sources.